Table 1

Patient characteristics

N (%) or mean±SD (n=142)
Age (years)69.7±11.4
Women51 (35.9%)
Weight (kg)85.7±21.1
CHA2DS2-VASc score3.0±1.7
 CHA2DS2-VASc ≤133 (23.2%)
 CHA2DS2-VASc ≥2109 (76.8%)
TOE completed142 (100%)
Thrombus on TOE13 (9.2%)
Type of AF
 Paroxysmal74 (52.1%)
 Non-paroxysmal68 (47.9%)
Diabetes34 (23.9%)
Arterial hypertension91 (64.1%)
GFR (mL/m²)68.7±21.3
Heart failure30 (21.1%)
Diastolic dysfunction32 (22.5%)
ICM26 (18.3%)
LVEF (%)51.8±14.0
LA diameter (mm)44.1±22.5
LA volume (mL)75.9±23.2
Mild mitral regurgitation9 (6.4%)
Mild aortic stenosis5 (3.9%)
History of stroke*19 (13.4%)
Vascular disease19 (13.4%)
History of TE3 (2.1%)
VKA16 (11.3%)
NOAC67 (47.2%)
Anticoagulation free59 (41.5%)
Beta-blockers78 (54.9%)
Antiarrhythmic drugs41 (28.9%)
D-dimers (ng/mL)880.2±760.4
DD50065 (45.8%)
DDAge86 (60.6%)
  • *Stroke includes cerebrovascular ischaemic accident, transient ischaemic attack, central or peripheral arterial embolism.

  • DD500, D-dimer <500 ng/mL; DDAge, D-dimer <10×patient’s age; GFR, glomerular filtration rate; ICM, ischaemic cardiomyopathy; LA, left atrium; LVEF, left ventricle ejection fraction; NOAC, novel oral anticoagulant; TE, thromboembolic events (pulmonary embolism and venous thromboembolism); VKA, vitamin K antagonists.